Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on January 30, 2024.
Webcast held in English: at 4:30 pm CET / 10:30 am ET: Registration link
Webcast held in French: at 6:00 pm CET / 12:00 pm ET: Registration link
Webcast replays will be available on Median's corporate website after the live sessions.
Back to press releases
Download 20240125_PR_Webcast_EN.pdf
About Median Technologies
Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer and metabolic disease diagnoses and treatments. Median's offerings, including iCRO for medical image analysis and management in oncology trials and eyonis, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. Since its inception, the French-based company, with a presence in the U.S. and China, has been recognized as an 'Innovative company' by BPI France and trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME).
Contacts
Median Technologies
Emmanuelle Leygues
Head of Corporate Marketing and Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP
Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN
Ghislaine Gasparetto
+33 6 21 10 49 24
ggasparetto@actifin.fr
(C) 2024 Electronic News Publishing, source ENP Newswire